Biopharmaceutical benchmarks 2022

Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.

Detalles Bibliográficos
Autores principales: Walsh, Gary, Walsh, Eithne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735008/
https://www.ncbi.nlm.nih.gov/pubmed/36471135
http://dx.doi.org/10.1038/s41587-022-01582-x
Descripción
Sumario:Monoclonal antibodies as a group continue to lead biopharmaceuticals in numbers of approvals and sales, although COVID-19 vaccines shot to the top of the list of highest-grossing individual products.

Ejemplares similares